DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

Sheraton Pentagon City Hotel

2024年3月12日 (火) 午前 7:30 - 2024年3月13日 (水) 午後 3:55

900 South Orme Street, Arlington, VA 22204, USA

Advertising and Promotion Regulatory Affairs Conference

Explore the current state of compliance for marketing both biopharmaceuticals and medical devices.

Session 10B: The Evolving World of Scientific Exchange

Session Chair(s)

Lynn  Bowen, PHD

Lynn Bowen, PHD

Vice President, Regulatory Affairs Advertising Promotion & Labeling, Alkermes, United States

The numerous and varied opportunities for scientific exchange (reactive and proactive) continue to introduce new challenges. This session aims to provide a regulatory background for these types of communications and discuss different examples of scientific exchange that various companies are currently participating in today, for example, medical booth activities, medical affairs activities, non-CME sponsored symposia, and more.

Learning Objective :
  • Describe the regulatory basis for scientific exchange
  • Evaluate different features of scientific exchange
  • Identify the different considerations in review of proactive scientific exchange

Speaker(s)

Lynn  Bowen, PHD

Lynn Bowen, PHD

Vice President, Regulatory Affairs Advertising Promotion & Labeling, Alkermes, United States

Heather  Banuelos, JD

Heather Banuelos, JD

Counsel, King & Spalding LLP, United States

Janet  Gottlieb, PHD

Janet Gottlieb, PHD

Head of Medical Review Solutions, Canopy Life Sciences, United States

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。